Null Cell Adenomas of the Pituitary Gland: an Institutional Review of Their Clinical Imaging and Behavioral Characteristics
- 18 November 2014
- journal article
- review article
- Published by Springer Nature in Endocrine Pathology
- Vol. 26 (1) , 63-70
Abstract
The aim of the study was to establish if the null cell adenoma (NCA) forms a distinct subgroup with unique clinicopathological characteristics within the nonfunctioning pituitary adenoma group particularly in relation to the silent gonadotroph adenomas (SGAs). We identified 31 patients with the pathological diagnosis of NCA verified by routine histology and immunohistochemistry with distinct differentiation from SGAs by an established negative testing for SF-1 at the Toronto Western Hospital between December 2004 and August 2010. We reviewed their demographic data, clinical features, magnetic resonance imaging, and the histologic variables: MIB-1, FGFR4, and P27. We compared these to 63 SGAs identified within the same period. All the NCAs were macroadenomas with diameter ranging from 15—57 mm and tumor volumes between 1.95–53.5 mm3. Preoperative cavernous sinus tumor growth was able to predict the presence of a residual after surgery (p = 0.023). Furthermore, preoperative cavernous sinus extension (p = 0.002) and negative P27 expression (p = 0.035) were able to independently predict the subsequent growth of the postoperative tumor residual. Comparing the NCA to SGA, we found that MIB-1 was higher in NCA (mean ± SD = 3.43 ± 2.76 %) compared to SGAs (mean ± SD = 2.49 ± 1.41 %) (p = 0.044). The preoperative and postoperative tumor volume doubling times (TVDTs) displayed a negative correlation in the SGA (r = −0.855, p = 0.002) while in the NCA, a positive correlation was evident (r = 0.718, p = 0.029). Our study suggests that the NCAs are a distinct group with differing behavioral characteristics from the SGAs. It also appears that the finding of cavernous sinus extension on preoperative imaging and a negative P27 expression on immunohistochemistry in NCAs may be valuable tools in predicting residual tumor growth which may impact on postoperative care.Keywords
This publication has 41 references indexed in Scilit:
- Clinical features of silent corticotroph adenomasActa Neurochirurgica, 2012
- Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patientsEuropean Journal of Endocrinology, 2010
- Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progressionJournal of Neurosurgery, 2009
- My approach to pathology of the pituitary glandJournal of Clinical Pathology, 2006
- Pathobiology of Pituitary Adenomas and CarcinomasNeurosurgery, 2006
- Expression of cell proliferation markers in pituitary adenomas ? correlation and clinical relevance of MIB-1 and anti-topoisomerase-II?Acta Neurochirurgica, 2004
- Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasivenessJournal of Neurosurgery, 2003
- Proliferation Index of Nonfunctioning Pituitary Adenomas: Correlations with Clinical Characteristics and Long-term Follow-up ResultsNeurosurgery, 2000
- MIB1 immunopositivity is associated with rapid regrowth of pituitary adenomasActa Neurochirurgica, 1997
- Histologic and immunohistochemical study of clinically non‐functioning pituitary adenomasPathology International, 1994